Follow
Zoe A Hughes
Zoe A Hughes
Gilgamesh Pharmaceuticals
Verified email at gilgameshpharmaceutical.com
Title
Cited by
Cited by
Year
Innovative approaches for the development of antidepressant drugs: current and future strategies
LE Schechter, RH Ring, CE Beyer, ZA Hughes, X Khawaja, JE Malberg, ...
NeuroRx 2 (4), 590-611, 2005
3342005
Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes
SJ Sukoff Rizzo, SJ Neal, ZA Hughes, M Beyna, S Rosenzweig-Lipson, ...
Translational psychiatry 2 (12), e199-e199, 2012
2562012
Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice
LC Baldan, KA Williams, JD Gallezot, V Pogorelov, M Rapanelli, ...
Neuron 81 (1), 77-90, 2014
2512014
Differentiating antidepressants of the future: efficacy and safety
S Rosenzweig-Lipson, CE Beyer, ZA Hughes, X Khawaja, SJ Rajarao, ...
Pharmacology & therapeutics 113 (1), 134-153, 2007
2492007
Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test
R Navarra, R Graf, Y Huang, S Logue, T Comery, Z Hughes, M Day
Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (1), 34-41, 2008
2112008
BACE1 (β-secretase) transgenic and knockout mice: identification of neurochemical deficits and behavioral changes
SM Harrison, AJ Harper, J Hawkins, G Duddy, E Grau, PL Pugh, ...
Molecular and Cellular Neuroscience 24 (3), 646-655, 2003
1902003
Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist
RH Ring, LE Schechter, SK Leonard, JM Dwyer, BJ Platt, R Graf, S Grauer, ...
Neuropharmacology 58 (1), 69-77, 2010
1682010
Critical data‐based re‐evaluation of minocycline as a putative specific microglia inhibitor
T Möller, F Bard, A Bhattacharya, K Biber, B Campbell, E Dale, C Eder, ...
Glia 64 (10), 1788-1794, 2016
1652016
LPA1 receptor-deficient mice have phenotypic changes observed in psychiatric disease
SM Harrison, C Reavill, G Brown, JT Brown, JE Cluderay, B Crook, ...
Molecular and Cellular Neuroscience 24 (4), 1170-1179, 2003
1592003
Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone
ZA Hughes, KR Starr, CJ Langmead, M Hill, GD Bartoszyk, JJ Hagan, ...
European journal of pharmacology 510 (1-2), 49-57, 2005
1502005
Inflammatory biomarkers in Alzheimer's disease plasma
AR Morgan, S Touchard, C Leckey, C O'Hagan, AJ Nevado-Holgado, ...
Alzheimer's & dementia 15 (6), 776-787, 2019
1402019
The BTBR mouse model of autism spectrum disorders has learning and attentional impairments and alterations in acetylcholine and kynurenic acid in prefrontal cortex
SM McTighe, SJ Neal, Q Lin, ZA Hughes, DG Smith
PloS one 8 (4), e62189, 2013
1322013
The metabotropic glutamate receptor 7 allosteric modulator AMN082: a monoaminergic agent in disguise?
SJS Rizzo, SK Leonard, A Gilbert, P Dollings, DL Smith, MY Zhang, L Di, ...
Journal of Pharmacology and Experimental Therapeutics 338 (1), 345-352, 2011
1102011
Central effects of urotensin-II following ICV administration in rats
J Gartlon, F Parker, DC Harrison, SA Douglas, TE Ashmeade, GJ Riley, ...
Psychopharmacology 155, 426-433, 2001
1042001
The orphan GPCR, GPR88, modulates function of the striatal dopamine system: a possible therapeutic target for psychiatric disorders?
SF Logue, SM Grauer, J Paulsen, R Graf, N Taylor, MA Sung, L Zhang, ...
Molecular and Cellular Neuroscience 42 (4), 438-447, 2009
982009
WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent
ZA Hughes, F Liu, BJ Platt, JM Dwyer, CM Pulicicchio, G Zhang, ...
Neuropharmacology 54 (7), 1136-1142, 2008
952008
Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation
CA Heidbreder, R Foxton, J Cilia, ZA Hughes, AJ Shah, A Atkins, ...
Psychopharmacology 156, 338-351, 2001
952001
High-performance liquid chromatography/tandem mass spectrometry assay for the rapid high sensitivity measurement of basal acetylcholine from microdialysates
MEP Hows, AJ Organ, S Murray, LA Dawson, R Foxton, C Heidbreder, ...
Journal of neuroscience methods 121 (1), 33-39, 2002
862002
Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression
ZA Hughes, SJ Neal, DL Smith, SJS Rizzo, CM Pulicicchio, S Lotarski, ...
Neuropharmacology 66, 202-214, 2013
842013
Development of a liquid chromatography/tandem mass spectrometry method for the quantitation of acetylcholine and related neurotransmitters in brain microdialysis samples
MY Zhang, ZA Hughes, EH Kerns, Q Lin, CE Beyer
Journal of pharmaceutical and biomedical analysis 44 (2), 586-593, 2007
832007
The system can't perform the operation now. Try again later.
Articles 1–20